INLYTA: payments to doctors
Payments that named INLYTA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 7,779
- Transactions
- 33,264
- Average per transaction
- $33
The per-transaction average — $33 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,779 providers the average total is $140, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $1,073,965 | 98.6% |
| PBG Puerto RICO LLC | $13,242 | 1.2% |
| Array Biopharma Inc | $1,394 | 0.1% |
| Pfizer Pharmaceuticals LLC | $631 | 0.1% |